To The Moon

chartWelcome to Natan's Notes! A quick weekly update on the stocks that I cover, the opportunities I’m exploring, and the thinking behind my portfolio allocation.Here’s what’s on deck this week:The recent decline of China’s E-commerce stocksHow I'm Managing My Exposure to the SectorThe recent decline of China’s E-commerce stocksAfter a strong start to the year for Chinese equities, especially $Alibaba(BABA)$ , which was up 75% YTD in just three months, the past few weeks have seen sharp pullbacks of 20–30% across the entire e-commerce sector.With most global markets hitting new all-time highs, I believe this sector now stands out as one of the most compelling investment opportunities.chartLooking at current valuations (NTM P/E), all major players

Updated on June 10th 2025.These stocks are up +32.4% on average YTD vs +3.0% of $S&P 500(.SPX)$ 1) $Alibaba(BABA)$ The biggest ecommerce in the world with >$1T GMV and the biggest cloud services provider in China at 12x Fwd PE. Natan's fair value: ~$162 (+34%)Image2) $TransMedics Group, Inc.(TMDX)$ Stock is up 2X YTD after the unjustified hard sell-off. The company is innovating the transplants market and they plan to achieve 10k transplants in 2028. Natan's fair value: ~$162 (+13%)Image3) $Meta Platforms, Inc.(META)$ Meta is my favorite big tech at current prices trading at 27X Fwd PE. The social networks giant i

1) $Alibaba(BABA)$ Y/Y SHARES CHANGE: -4.1% 2) $PayPal(PYPL)$ Y/Y SHARES CHANGE: -6.8% 3) $Adobe(ADBE)$ Y/Y SHARES CHANGE: -5.0% 4) $eBay(EBAY)$ Y/Y SHARES CHANGE: -8.5% 5) $FISERV INC(FI)$ Y/Y SHARES CHANGE: -5.1% 6) $Academy Sports & Outdoors, Inc.(ASO)$ Y/Y SHARES CHANGE: -10.0% 7) $Booking Holdings(BKNG)$ Y/Y SHARES CHANGE: -4.7% 8) $Yum China Holdings, Inc.(YUMC)$ Y/Y SHARES CHANGE: -6.2% 9) $Wells Fargo(WFC)

$Moderna, Inc.(MRNA)$   is down 94% from ATH and is trading near cash! In this thread I'll tell you what's going on and why I own the stock. Over the past year, shares of Moderna, the American biotech company founded in 2010 to develop mRNA-based vaccines and therapies, have been in steady decline. While a series of negative events has occurred, there are nonetheless a few potential catalysts worth considering. The stock has lost approximately 94% of its value from the highs reached during the pandemic. Yet, the company has built a pipeline of 45 candidates, including 8 assets in Phase 3 and many more in Phase 2, investing over 20 billion dollars in research and development. Image Image Image Image Today’s market cap of $11 billion

Natan YTD: +18.9% $S&P 500(.SPX)$ : +0.5%  TOTAL RETURNS (Jan 2022) Natan's portfolio: +79.5% *Benchmark: +23.0% S&P500: +29.6% My biggest positions: $PDD Holdings Inc(PDD)$  $TransMedics Group, Inc.(TMDX)$ $Alibaba(BABA)$ $Robinhood(HOOD)$  $UnitedHealth(UNH)$   ALLOCATION BY COUNTRY: 🇺🇸 US: 63% 🇨🇳 China: 32% 🇨🇦 Canada: 4% 🇨🇭 Switzerland: 1% - - - - - - - - - - - - - - - - - - - * 𝘉𝘦𝘯𝘤𝘩𝘮𝘢𝘳𝘬 𝘪𝘴 𝘤𝘢𝘭𝘤𝘶𝘭𝘢𝘵𝘦𝘥 𝘢𝘴 𝘢 𝘸𝘦𝘪𝘨𝘩𝘵𝘦𝘥 𝘢𝘷𝘦𝘳𝘢𝘨𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘧𝘰𝘭𝘭𝘰𝘸𝘪𝘯𝘨 𝘳𝘦𝘵𝘶𝘳𝘯𝘴: - 60% 𝘕𝘢𝘴𝘥𝘢𝘲 𝘊𝘰𝘮𝘱𝘰𝘴𝘪𝘵𝘦 𝘌𝘛𝘍 -